Murali D Bandla

Title: Murali D Bandla: Innovator in Immunoassay Technology

Introduction

Murali D Bandla is a notable inventor based in Granger, Indiana, who has made significant contributions to the field of immunoassay technology. His innovative methods are particularly useful for detecting microorganisms that produce extracellular polysaccharides and lipopolysaccharides.

Latest Patents

Murali D Bandla holds a patent for an immunoassay and method of use. This method is designed for detecting extracellular polysaccharide (EPS) and/or lipopolysaccharide (LPS) producing microorganisms. The process involves extracting EPS and/or LPS from a sample using cetyltrimethylammonium bromide (CTAB) to create molecular aggregates. These aggregates are then preferentially bound to colored polystyrene latex particles, allowing for detection through a lateral flow immunoassay apparatus that has immobilized antibodies specific for the EPS and/or LPS. This method can also be utilized to detect specific viruses, such as those from the potyviridae or tobamoviridae groups.

Career Highlights

Murali D Bandla is currently employed at Agdia Inc., where he continues to develop and refine his innovative methods in immunoassay technology. His work has contributed to advancements in the detection of various microorganisms, enhancing the capabilities of diagnostic tools in the field.

Collaborations

Some of Murali's coworkers include Matthew R Chambers and Chester L Sutula, who collaborate with him on various projects at Agdia Inc. Their combined expertise fosters an environment of innovation and progress in their research endeavors.

Conclusion

Murali D Bandla's contributions to immunoassay technology exemplify the impact of innovative thinking in the field of microbiology. His patent for a method of detecting EPS and LPS producing microorganisms showcases his commitment to advancing diagnostic capabilities.